Pharmafile Logo
Pharmafocus logo
Advanced Search

Milburn defiant in face of foundation trust revolt

November 3, 2003

News

Parliamentary showdown for foundation trust plans

November 3, 2003

Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS …

News

Smallpox vaccine puts Acambis into profit

November 3, 2003
Research and Development

News

Generic threat to Lilly’s biggest seller

November 3, 2003
Sales and Marketing

A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …

News

Industry lukewarm on new labelling guidelines

October 31, 2003
Sales and Marketing

New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.The Government hopes the best …

News

GSK launches prostate drug

October 31, 2003
Sales and Marketing

GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.The …

News

Consultants threaten to quit

October 31, 2003

More than a quarter of hospital consultants are ready to resign or retire from the NHS if they dont receive …

News

GSK in running for Pfizer incontinence drug

October 31, 2003
Sales and Marketing

GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with …

News

Trusts warned over fixing waiting times

October 31, 2003

All NHS trusts will have to review how they report waiting times after a spot check found widespread distortion and …

News

Levitra brings three dimensions to ED market

October 31, 2003

Bayer and GlaxoSmithKline's new erectile dysfunction treatment Levitra has been launched in the UK, its first market after receiving European …

News

Staff shortages holding back NHS progress

October 31, 2003

A chronic shortage of staff in some parts of the NHS is holding back improvements to the service, according to …

News

BMS attempts to distance itself from fraud allegations

October 31, 2003

Bristol-Myers Squibb is attempting to draw a line under allegations of fraud and financial misconduct by downgrading earnings as far …

News

Industry reputation under fire at home and abroad

October 31, 2003

Continuing conflict over access to medicines in developing countries and growing distrust of big pharma in domestic markets is threatening …

News

Germany delay undermines Crestor confidence

October 31, 2003

AstraZeneca's cholesterol treatment Crestor has been dealt a serious blow following Germanys withdrawal from a pan-European approval process.Germany, the EU's …

News

Parliamentary showdown for foundation trust plans

October 31, 2003

Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS …

News

Smallpox vaccine puts Acambis into profit

October 31, 2003

Vaccine company Acambis has joined rivals PowderJect and Celltech in the elite group of profitable UK biotech companies.The company recorded …

News

Shire appoints Emmens as new chief executive

October 31, 2003

Matthew Emmens, former head of Merck KGaA's global prescription group, has been appointed as the new Chief Executive of Shire …

News

Paediatric trials to be mandatory in US

October 31, 2003

Plans to make clinical trials mandatory for all drugs intended for children are progressing in the US.The Paediatric Research Equity …

News

Savings boost GSK outlook

October 31, 2003

News

Pfizer ends obesity drug partnership

October 31, 2003

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025